United States · FDA National Drug Code directory
PAPAVERINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54288-142_afdd82fd-269d-4d51-b3f1-515ce7ead96d
- Product NDC
- 54288-142
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Papaverine Hydrochloride
- Labeler
- BPI Labs LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20210710
- Source listing expiry
- 20261231
Source-listed ingredients
- PAPAVERINE HYDROCHLORIDE — 30 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (54288-142-10) / 2 mL in 1 VIAL (54288-142-01) · 54288-142-10
- 25 VIAL in 1 CARTON (54288-142-25) / 2 mL in 1 VIAL (54288-142-01) · 54288-142-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →